16-1972204-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_006453.3(TBL3):āc.40A>Gā(p.Asn14Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000357 in 1,401,696 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006453.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBL3 | ENST00000568546.6 | c.40A>G | p.Asn14Asp | missense_variant, splice_region_variant | 1/22 | 1 | NM_006453.3 | ENSP00000454836.1 | ||
TBL3 | ENST00000561907.5 | n.40A>G | splice_region_variant, non_coding_transcript_exon_variant | 1/6 | 2 | ENSP00000454735.1 | ||||
TBL3 | ENST00000569628.5 | n.119A>G | splice_region_variant, non_coding_transcript_exon_variant | 1/21 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152192Hom.: 1 Cov.: 33
GnomAD4 exome AF: 0.0000360 AC: 45AN: 1249504Hom.: 0 Cov.: 30 AF XY: 0.0000412 AC XY: 25AN XY: 606164
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152192Hom.: 1 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.40A>G (p.N14D) alteration is located in exon 1 (coding exon 1) of the TBL3 gene. This alteration results from a A to G substitution at nucleotide position 40, causing the asparagine (N) at amino acid position 14 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at